Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
Washout with a one-week half-life: the arithmetic — does this still hold? posts 31–46
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
I read post #31 twice before replying, because I had assumed the opposite.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
This follows post #31 rather than contradicting it.
Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what you already believed has not changed anything.
Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to reach baseline. Using that washout period in a before-after design strengthens the inference.
Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard to miss) but partial blinding is possible (measuring something objective without knowing whether you took it today).
Picking up post #35: that is the part I would want checked first.
Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to reach baseline. Using that washout period in a before-after design strengthens the inference.
Worth separating two things that post #35 runs together.
Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you understand their contribution to the result.
post #40 is right about the mechanism and I think understates the practical bit.
Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met). Not deciding in advance means stopping when the result satisfies you, which is bias.
Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what you already believed has not changed anything.
Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard to miss) but partial blinding is possible (measuring something objective without knowing whether you took it today).
I read post #42 twice before replying, because I had assumed the opposite.
Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less vulnerable but not immune.
post #44 answers the question as asked. The question underneath it is different.
Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people different from you.
On post #42 — agreed on the reasoning, with one qualification.
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
This topic was referenced in
- Why most self-reports here are not experiments, and that is fineResearch Methods › N-of-1 designs · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in…
|
2 | 46k | 11mo | |
|
Coming back to: Why most self-reports here are not experiments, and that is fine
The question in the title: Why most self-reports here are not experiments, and that is fine I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med , 2016) with…
|
+56 | 62 | 11k | 4mo |
|
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
|
+74 | 80 | 17k | 2d |
|
Pre-registering a personal experiment, seriously
Pre-registering a personal experiment, seriously — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SUSTAIN 6 ( N Engl J Med , 2016) and finding the…
|
+96 | 119 | 58k | 14mo |
|
Pre-registering a personal experiment, seriously — a second dataset
Posting this under the heading it deserves: Pre-registering a personal experiment, seriously — a second dataset Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of…
|
+60 | 66 | 35k | 3mo |
Related topics — sharing the tags confounding, data table, worked example
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold?
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand…
|
+14 | 18 | 3.4k | 2mo |
|
Feature request: should a dose-equivalence tool exist at all?
Feature request: should a dose-equivalence tool exist at all? — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first…
|
+21 | 25 | 4.8k | 18mo |
|
Revisiting: Bioimpedance and hydration: why the number moves
Posting this under the heading it deserves: Revisiting: Bioimpedance and hydration: why the number moves Everything below is what sits behind that. Longitudinal report with the method stated, because a number…
|
2 | 2.8k | 1mo | |
|
Contributing data without breaching anyone's privacy
Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
+65 | 71 | 839 | 5mo |
|
Titles that describe the question, not the situation — what changed since
Posting this under the heading it deserves: Titles that describe the question, not the situation — what changed since Everything below is what sits behind that. Question in the title. Context below, and I…
|
+29 | 33 | 29k | 10mo |